196 related articles for article (PubMed ID: 23275143)
1. Prognostic significance of epigenetic inactivation of p16, p15, MGMT and DAPK genes in follicular lymphoma.
Krajnović M; Radojković M; Davidović R; Dimitrijević B; Krtolica K
Med Oncol; 2013 Mar; 30(1):441. PubMed ID: 23275143
[TBL] [Abstract][Full Text] [Related]
2. Azacytidine inhibits the proliferation of human promyelocytic leukemia cells (HL60) by demethylation of MGMT, DAPK and p16 genes.
Su Y; Xu H; Xu Y; Yu J; Xian Y; Luo Q
Hematology; 2012 Jan; 17(1):41-6. PubMed ID: 22549447
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of p15 gene in diffuse - large B-cell lymphoma: association with less aggressiveness of the disease.
Krajnović M; Jovanović MP; Mihaljević B; Anđelić B; Tarabar O; Knežević-Ušaj S; Krtolica K
Clin Transl Sci; 2014 Oct; 7(5):384-90. PubMed ID: 24815848
[TBL] [Abstract][Full Text] [Related]
4. Methylation status of nine tumor suppressor genes in multiple myeloma.
Braggio E; Maiolino A; Gouveia ME; Magalhães R; Souto Filho JT; Garnica M; Nucci M; Renault IZ
Int J Hematol; 2010 Jan; 91(1):87-96. PubMed ID: 20037750
[TBL] [Abstract][Full Text] [Related]
5. Concomitant aberrant methylation of p15 and MGMT genes in acute myeloid leukemia: association with a particular immunophenotype of blast cells.
Kraguljac Kurtović N; Krajnović M; Bogdanović A; Suvajdžić N; Jovanović J; Dimitrijević B; Colović M; Krtolica K
Med Oncol; 2012 Dec; 29(5):3547-56. PubMed ID: 22772967
[TBL] [Abstract][Full Text] [Related]
6. Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanoma.
Rastetter M; Schagdarsurengin U; Lahtz C; Fiedler E; Marsch WCh; Dammann R; Helmbold P
Histol Histopathol; 2007 Sep; 22(9):1005-15. PubMed ID: 17523078
[TBL] [Abstract][Full Text] [Related]
7. Detecting methylation patterns of p16, MGMT, DAPK and E-cadherin genes in multiple myeloma patients.
Yuregir OO; Yurtcu E; Kizilkilic E; Kocer NE; Ozdogu H; Sahin FI
Int J Lab Hematol; 2010 Apr; 32(2):142-9. PubMed ID: 19302404
[TBL] [Abstract][Full Text] [Related]
8. Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma.
Chim CS; Wong KY; Loong F; Lam WW; Srivastava G
Hum Pathol; 2007 Dec; 38(12):1849-57. PubMed ID: 17900658
[TBL] [Abstract][Full Text] [Related]
9. Comparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCC.
Sun W; Zaboli D; Liu Y; Arnaoutakis D; Khan T; Wang H; Koch W; Khan Z; Califano JA
PLoS One; 2012; 7(3):e33642. PubMed ID: 22438973
[TBL] [Abstract][Full Text] [Related]
10. PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients.
Buckingham L; Penfield Faber L; Kim A; Liptay M; Barger C; Basu S; Fidler M; Walters K; Bonomi P; Coon J
Int J Cancer; 2010 Apr; 126(7):1630-9. PubMed ID: 19795445
[TBL] [Abstract][Full Text] [Related]
11. Comethylation of p16 and MGMT genes in colorectal carcinoma: correlation with clinicopathological features and prognostic value.
Krtolica K; Krajnovic M; Usaj-Knezevic S; Babic D; Jovanovic D; Dimitrijevic B
World J Gastroenterol; 2007 Feb; 13(8):1187-94. PubMed ID: 17451198
[TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
13. An inverse correlation between Interleukin-6 and select gene promoter methylation in patients with gastric cancer.
Tang LP; Cho CH; Hui WM; Huang C; Chu KM; Xia HH; Lam SK; Rashid A; Wong BC; Chan AO
Digestion; 2006; 74(2):85-90. PubMed ID: 17139167
[TBL] [Abstract][Full Text] [Related]
14. p15 promoter methylation - a novel prognostic marker in glioblastoma patients.
Wemmert S; Bettscheider M; Alt S; Ketter R; Kammers K; Feiden W; Steudel WI; Rahnenführer J; Urbschat S
Int J Oncol; 2009 Jun; 34(6):1743-8. PubMed ID: 19424593
[TBL] [Abstract][Full Text] [Related]
15. Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression.
Iliopoulos D; Oikonomou P; Messinis I; Tsezou A
Oncol Rep; 2009 Jul; 22(1):199-204. PubMed ID: 19513524
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion.
Katayama H; Hiraki A; Aoe K; Fujiwara K; Matsuo K; Maeda T; Murakami T; Toyooka S; Sugi K; Ueoka H; Tanimoto M
Int J Cancer; 2007 May; 120(10):2191-5. PubMed ID: 17285579
[TBL] [Abstract][Full Text] [Related]
17. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma.
Nakamichi I; Tomita Y; Zhang B; Sugiyama H; Kanakura Y; Fukuhara S; Hino M; Kanamaru A; Ogawa H; Aozasa K
Ann Hematol; 2007 Aug; 86(8):557-64. PubMed ID: 17508213
[TBL] [Abstract][Full Text] [Related]
18. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemia.
Takeuchi S; Matsushita M; Zimmermann M; Ikezoe T; Komatsu N; Seriu T; Schrappe M; Bartram CR; Koeffler HP
Leuk Res; 2011 Oct; 35(10):1345-9. PubMed ID: 21592569
[TBL] [Abstract][Full Text] [Related]
20. Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer.
Sun W; Zaboli D; Wang H; Liu Y; Arnaoutakis D; Khan T; Khan Z; Koch WM; Califano JA
Clin Cancer Res; 2012 Feb; 18(4):1082-91. PubMed ID: 22228635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
